topical spray-on drug formulation

Eluciderm is a clinical-stage regenerative medicine small-molecule pharmaceutical company based in San Diego, CA. It has developed a platform of small molecules that selectively modulate multiple Poly(ADP-ribose) polymerase (PARP) enzymes to guide tissue repair away from fibrosis and toward organized tissue regeneration. Its lead candidate ELU42 is a topical spray-on therapy in a Phase I/IIA clinical trial for diabetic foot ulcers.

Read more

clinical stage drug developmentregenerative medicine researchsmall-molecule PARP modulation platform